Talk:Anthracycline

Idarubicin structure
There is a mistake - idarubicin has no methoxy group at C-4 position (4-demethoxydaunorubicin). Please correct this mistake, because in these pictures there's no difference between daunorubicin and idarubicin.
 * Fixed here. Fvasconcellos (t·c) 18:28, 8 June 2008 (UTC)

Useful references
For future expansion:   Fvasconcellos (t·c) 18:28, 8 June 2008 (UTC)
 * Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
 * The Cardiotoxicology of Anthracycline Chemotherapeutics: TRANSLATING MOLECULAR MECHANISM INTO PREVENTATIVE MEDICINE
 * Cardiovascular Complications of Cancer Therapy

New ones in clinical trials
eg: In 2016 GPX-150 was granted Orphan Drug designation by US FDA. - Rod57 (talk) 00:30, 11 February 2016 (UTC)

cardiotoxicity
I think it's classically described as decreased ejection fraction ultimately leading to dilated cardiomyopathy. — Preceding unsigned comment added by 99.228.106.37 (talk) 18:02, 31 August 2018 (UTC)